论文部分内容阅读
播散性血管内凝血(DIC)是由感染、恶性肿瘤、白血病或其他疾病所引起的一种严重并发症,具有特殊的病理过程。DIC 时微血管内的血液呈高凝状态,出现多发性微血栓,引起组织器管的机能障碍;同时由于消耗性凝血障碍及纤维蛋白溶解亢进,可导致出血及出现其他临床症状。对本病的治疗,一般除针对引起 DIC 的病因(原发病)的治疗外,尚有:(1)抗凝疗法;(2)血小板抑制剂;(3)血栓溶解疗法;(4)对消耗性凝血障碍给以血浆、血小板等的补充疗法。目前认为,肝
Disseminated intravascular coagulation (DIC) is a serious complication caused by infection, malignancy, leukemia or other diseases and has a special pathological process. DIC microvascular blood hypercoagulable state, the emergence of multiple microthrombus, causing the organizer tube dysfunction; the same time due to consumptive coagulation disorders and fibrinolytic hyperkeratosis, can lead to bleeding and other clinical symptoms. The treatment of this disease, in addition to the general cause of the disease caused by DIC (primary disease) treatment, there are: (1) anticoagulant therapy; (2) platelet inhibitors; (3) thrombolytic therapy; (4) Consumptive coagulopathy to plasma, platelets and other complementary therapy. Currently that liver